ArticleNature cancer2021
Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia.
Mari Hashimoto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it